Jaundice of the Eyes

What is Jaundice of the Eyes?

Jaundice of the eyes, also known as icteric sclerae or “yellowing of the whites of the eyes,” occurs when the sclera (the tough, white outer layer of the eyeball) takes on a yellow hue. The discoloration is most easily seen when the eyes are open and the lighting is good. It reflects an excess of bilirubin—a yellow pigment produced when red blood cells break down—in the bloodstream. While the eye change is often subtle, it can be a valuable early clue that a systemic problem is affecting the liver, gallbladder, pancreas, or red‑blood‑cell turnover.

Common Causes

Jaundice of the eyes is a symptom, not a disease. Below are the most frequent conditions that can lead to icteric sclerae:

• Acute viral hepatitis (A, B, C, D, E) – Inflammation of the liver interferes with bilirubin processing.
• Chronic liver disease (cirrhosis, alcoholic liver disease, non‑alcoholic fatty liver disease) – Long‑term scarring reduces the liver’s ability to clear bilirubin.
• Bile duct obstruction – Gallstones, tumors, or strictures block bilirubin flow into the intestine.
• Hemolytic anemia – Excess destruction of red blood cells releases large amounts of bilirubin.
• Gilbert’s syndrome – A common, benign genetic disorder that reduces the liver’s ability to conjugate bilirubin.
• Pancreatic cancer (head of the pancreas) – Can compress the common bile duct.
• Clostridium difficile or other severe infections – Sepsis can impair liver function.
• Medication‑induced liver injury – Acetaminophen overdose, certain antibiotics, anticonvulsants, and herbal supplements.
• Neonatal physiologic jaundice – Common in newborns; bilirubin may temporarily discolor the sclera.
• Rare metabolic disorders – e.g., Crigler‑Najjar syndrome, Dubin‑Johnson syndrome.

Associated Symptoms

Because icteric sclerae usually signal a problem with bilirubin metabolism, other systemic signs often appear. Common co‑presenting symptoms include:

• Yellowing of the skin (especially on the palms and soles)
• Dark urine (bilirubin in urine)
• Pale or clay‑colored stools (lack of bilirubin reaching the intestine)
• Abdominal pain – particularly in the right upper quadrant (liver, gallbladder) or epigastrium (pancreas)
• Pruritus (itchy skin) due to bile‑salt deposition
• Fatigue, weakness, or malaise
• Unexplained weight loss
• Nausea, vomiting or loss of appetite
• Fever or chills if an infection is present
• Enlarged liver or spleen felt on exam

When to See a Doctor

Jaundice of the eyes is rarely an emergency on its own, but it often signals an underlying condition that needs prompt evaluation. Seek medical attention if you notice:

• The yellow tint persists for more than 24–48 hours.
• Yellowing spreads to the skin, especially the face, neck, or chest.
• You develop any of the associated symptoms listed above (dark urine, abdominal pain, fever, etc.).
• You have a history of liver disease, gallstones, or chronic alcoholism.
• You are taking medications known to affect the liver and notice new yellowing.
• You are pregnant and develop jaundice (possible cholestasis of pregnancy).
• You experience sudden, severe abdominal pain or swelling.

Infants with jaundice should be evaluated by a pediatrician within the first 24 hours if the sclerae are yellow, especially if the newborn is less than 2 weeks old or appears lethargic.

Diagnosis

Evaluation aims to determine why bilirubin is high and whether the problem is pre‑hepatic (before the liver), hepatic (within the liver), or post‑hepatic (after the liver). Typical steps include:

History and Physical Exam

• Detailed medication, alcohol, and supplement use.
• Travel, sexual, and occupational exposures (risk for viral hepatitis).
• Family history of liver or blood‑disorder conditions.
• Focused abdominal exam for tenderness, liver size, and signs of ascites.

Laboratory Tests

• Serum bilirubin – total and direct (conjugated) fractions.
• Liver function panel – ALT, AST, ALP, GGT, albumin, PT/INR.
• Complete blood count (CBC) – looks for anemia or infection.
• Hemolysis work‑up if pre‑hepatic cause suspected (LDH, haptoglobin, peripheral smear).
• Viral hepatitis serologies (HBsAg, anti‑HBc, anti‑HCV, HAV IgM, etc.).
• Autoimmune markers (ANA, ASMA, anti‑LKM) if autoimmune hepatitis is considered.

Imaging Studies

• Abdominal ultrasound – First‑line to assess liver texture, gallstones, bile‑duct dilation.
• CT or MRI of the abdomen if a mass or pancreatic tumor is suspected.
• MRCP (magnetic resonance cholangiopancreatography) for detailed bile‑duct visualization.

Special Procedures

• Endoscopic retrograde cholangiopancreatography (ERCP) – both diagnostic and therapeutic for bile‑duct obstruction.
• Liver biopsy – rarely needed but valuable for unclear chronic liver disease.

Treatment Options

Treatment is directed at the underlying cause; the yellow sclerae usually resolve once bilirubin levels normalize.

Medical Interventions

• Antiviral therapy for chronic hepatitis B or C (e.g., entecavir, tenofovir, direct‑acting antivirals).
• Corticosteroids for autoimmune hepatitis.
• Ursodeoxycholic acid for certain cholestatic conditions.
• Chelation or exchange transfusion in severe neonatal hyperbilirubinemia.
• Antibiotics** for bacterial cholangitis or sepsis.
• Phlebotomy or chelation in hemolytic anemia (e.g., sickle‑cell disease, G6PD deficiency).
• Surgery or endoscopic stone removal (laparoscopic cholecystectomy, ERCP with sphincterotomy) for gallstone‑related obstruction.
• Oncologic therapies (chemotherapy, radiation, targeted agents) for malignancies causing blockage.